1. HDAC-an important target for improving tumor radiotherapy resistance
   Rui Ling et al, 2023, Frontiers in Oncology CrossRef
2. Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c-myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses
   Jin Qian et al, 2022, BioMed Research International CrossRef
3. Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma
   Don W. Coulter et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef
4. The roles of glycolysis in osteosarcoma
   Zuxi Feng et al, 2022, Frontiers in Pharmacology CrossRef
5. Radiation Response of Human Leukemia/Lymphoma Cells was Improved by 7-Geranyloxycoumarin
   Ramin Bagheri et al, 2022, Dose-Response CrossRef
6. ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma
   Yanlin Song et al, 2023, Cancer Letters CrossRef